Intriguingly, significant enrichment of these pathways was observed in cancer cells with Uba1 depletion or TAK-243 treatment in vitro, particularly in the presence of IFN-γ stimulation (Fig. 5D; Supplementary Fig. S5E). This evidence concerns the gene CDK9 and cancer.